Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn’s Disease

作者
Alessandra Belvedere,Gerti Dajti,Cristina Larotonda,Laura Francesca Angelicchio,Fernando Rizzello,Paolo Gionchetti,Gilberto Poggioli,Matteo Rottoli
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:12 (4): 1392-1392 被引量:1
标识
DOI:10.3390/jcm12041392
摘要

Background: Anastomotic leak (AL) remains one of the most relevant complications after intestinal resection for Crohn’s disease (CD). While surgery has always been considered the standard treatment for perianastomotic collection, percutaneous drainage (PD) has been proposed as a potential alternative. Methods: Retrospective study in consecutive patients treated with either PD or surgery for AL after intestinal resection for CD between 2004 and 2022. AL was defined as a perianastomotic fluid collection confirmed by radiological findings. Patients with generalized peritonitis or clinical instability were excluded. Primary aim: To compare the success rate of PD vs. surgery. Secondary aims: To compare the outcomes at 90 days after the procedures; to identify the variables associated with the indication for PD. Results: A total of 47 patients were included, of which 25 (53%) underwent PD and 22 (47%) surgery. The success rate was 84% in the PD and 95% in the surgery group (p = 0.20). There were no significant differences between the PD and surgery group in postoperative medical and surgical complications, discharge, readmission or reoperation rates at 90 days. PD was more likely to be performed in patients with later diagnosis of AL (OR 1.25, 95% CI 1.03–1.53, p = 0.027), undergoing ileo-colic anastomosis alone (OR 3.72, 95% CI 2.29–12.45, p = 0.034) and treated after 2016 (OR 6.36, 95% CI 1.04–39.03, p = 0.046). Conclusion: The present study suggests that PD is a safe and effective procedure to treat anastomotic leak and perianastomotic collection in CD patients. PD should be indicated in all eligible patients as an effective alternative to surgery.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
脑洞疼应助YY采纳,获得10
刚刚
molihuakai应助十一号采纳,获得10
刚刚
dadada发布了新的文献求助10
刚刚
清爽雁开完成签到 ,获得积分10
1秒前
活力小笼包完成签到,获得积分10
1秒前
panghu完成签到,获得积分10
1秒前
吴茜红完成签到,获得积分10
1秒前
闪电小子完成签到,获得积分10
1秒前
沙漠猫完成签到,获得积分10
1秒前
Carol完成签到,获得积分10
2秒前
2秒前
DuanJN完成签到,获得积分10
2秒前
超超完成签到,获得积分10
2秒前
拼搏翠安发布了新的文献求助10
3秒前
万能图书馆应助赵晨硕采纳,获得10
3秒前
呼啦啦树獭完成签到,获得积分10
3秒前
3秒前
LXAYUI发布了新的文献求助10
3秒前
orixero应助安静大雁采纳,获得10
4秒前
单复天完成签到,获得积分10
5秒前
5秒前
正直的松鼠完成签到 ,获得积分10
5秒前
5秒前
小蘑菇应助王泽采纳,获得10
5秒前
5Enu完成签到,获得积分10
6秒前
JamesPei应助pinellia采纳,获得10
6秒前
大号安全蛋完成签到,获得积分10
6秒前
英俊的铭应助疲倦之躯采纳,获得10
6秒前
Hello应助萌酱采纳,获得10
6秒前
谢之阳发布了新的文献求助10
6秒前
今后应助思泽采纳,获得10
7秒前
7秒前
Jasper应助王小橘采纳,获得10
7秒前
oohQoo完成签到,获得积分10
7秒前
李健应助niliu730323143采纳,获得10
8秒前
bkagyin应助dadada采纳,获得10
8秒前
5Enu发布了新的文献求助10
8秒前
yukexin应助拼搏翠安采纳,获得10
9秒前
9秒前
长生久视完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Autoparametric Resonance in Mechanical Systems 1000
Effects of Two Weeks of Red Light Therapy on Choroidal Thickness and Axial Length in Young Adults 700
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 600
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Auslegungsgeschichte 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7662893
求助须知:如何正确求助?哪些是违规求助? 9232760
关于积分的说明 19859105
捐赠科研通 7231360
什么是DOI,文献DOI怎么找? 3282297
关于科研通互助平台的介绍 2441748
邀请新用户注册赠送积分活动 2283215